Holdings of Biotechnology Fund
Rydex Variable Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 13.5M $ including 13.4M $ in equities, 99.4 %
- Positions
- 70 in 9 countries
- Top ten
- 36.2 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | AbbVie Inc | 4,369 | 1.1M $ | 8.15 % |
| 2 | Amgen Inc | 1,876 | 679.3K $ | 5.04 % |
| 3 | Gilead Sciences Inc | 4,786 | 604.7K $ | 4.49 % |
| 4 | Vertex Pharmaceuticals Inc | 1,170 | 581.2K $ | 4.31 % |
| 5 | Regeneron Pharmaceuticals Inc | 633 | 394.7K $ | 2.93 % |
| 6 | REVOLUTION MEDICINES INC | 1,781 | 333.5K $ | 2.47 % |
| 7 | ALNYLAM PHARMACEUTICALS INC | 1,055 | 317.6K $ | 2.36 % |
| 8 | BEONE MEDICINES LTD | 1,026 | 292.4K $ | 2.17 % |
| 9 | MODERNA INC | 4,130 | 289.2K $ | 2.15 % |
| 10 | Biogen Inc | 1,325 | 286.3K $ | 2.12 % |
| 11 | NATERA INC | 1,050 | 285K $ | 2.11 % |
| 12 | ROYALTY PHARMA PLC | 4,830 | 270.8K $ | 2.01 % |
| 13 | Illumina Inc | 1,481 | 260.4K $ | 1.93 % |
| 14 | Insmed Inc | 2,262 | 241.2K $ | 1.79 % |
| 15 | United Therapeutics Corp | 428 | 231.9K $ | 1.72 % |
| 16 | GUARDANT HEALTH INC | 1,542 | 231.3K $ | 1.72 % |
| 17 | Roivant Sciences Ltd | 6,308 | 223.2K $ | 1.66 % |
| 18 | Incyte Corp | 1,920 | 217.7K $ | 1.61 % |
| 19 | VIATRIS INC | 13,157 | 208.9K $ | 1.55 % |
| 20 | Neurocrine Biosciences Inc | 1,216 | 204.9K $ | 1.52 % |
| 21 | Argenx SE | 215 | 199.5K $ | 1.48 % |
| 22 | JAZZ PHARMACEUTICALS PLC | 791 | 190.6K $ | 1.41 % |
| 23 | Bridgebio Pharma Inc | 2,499 | 186.1K $ | 1.38 % |
| 24 | IONIS PHARMACEUTICALS INC | 2,295 | 182K $ | 1.35 % |
| 25 | CYTOKINETICS INC | 2,133 | 181.7K $ | 1.35 % |
| 26 | Exelixis Inc | 3,292 | 179.1K $ | 1.33 % |
| 27 | Alkermes PLC | 3,375 | 176.8K $ | 1.31 % |
| 28 | Arrowhead Pharmaceuticals Inc | 2,061 | 168K $ | 1.25 % |
| 29 | BioMarin Pharmaceutical Inc | 2,915 | 166.8K $ | 1.24 % |
| 30 | AstraZeneca PLC | 870 | 165K $ | 1.22 % |
| 31 | Halozyme Therapeutics Inc | 2,014 | 157.6K $ | 1.17 % |
| 32 | BioNTech SE | 1,678 | 156.1K $ | 1.16 % |
| 33 | CRISPR Therapeutics AG | 2,857 | 155.8K $ | 1.16 % |
| 34 | VAXCYTE INC | 2,675 | 155.5K $ | 1.15 % |
| 35 | TG THERAPEUTICS INC | 2,657 | 146K $ | 1.08 % |
| 36 | Medpace Holdings Inc | 262 | 138.8K $ | 1.03 % |
| 37 | Apogee Therapeutics Inc | 1,034 | 137.2K $ | 1.02 % |
| 38 | COGENT BIOSCIENCES INC | 3,488 | 135K $ | 1.00 % |
| 39 | TWIST BIOSCIENCE CORP | 1,289 | 132.6K $ | 0.98 % |
| 40 | PTC Therapeutics Inc | 1,625 | 132.6K $ | 0.98 % |
| 41 | Nuvalent Inc | 1,072 | 132.4K $ | 0.98 % |
| 42 | Scholar Rock Holding Corp | 2,407 | 132.4K $ | 0.98 % |
| 43 | Axsome Therapeutics Inc | 528 | 129.2K $ | 0.96 % |
| 44 | CG ONCOLOGY INC | 1,814 | 128.9K $ | 0.96 % |
| 45 | Krystal Biotech Inc | 335 | 124.5K $ | 0.92 % |
| 46 | Viking Therapeutics Inc | 3,094 | 120.7K $ | 0.90 % |
| 47 | TRAVERE THERAPEUTICS INC | 2,124 | 120.7K $ | 0.90 % |
| 48 | Protagonist Therapeutics Inc | 974 | 119.4K $ | 0.89 % |
| 49 | Ascendis Pharma A/S | 447 | 119.2K $ | 0.88 % |
| 50 | Veracyte Inc | 2,012 | 118.2K $ | 0.88 % |
| 51 | Liquidia Corp | 1,457 | 116.2K $ | 0.86 % |
| 52 | KYMERA THERAPEUTICS INC | 978 | 112.1K $ | 0.83 % |
| 53 | Madrigal Pharmaceuticals Inc | 199 | 106.9K $ | 0.79 % |
| 54 | Ultragenyx Pharmaceutical Inc | 3,106 | 103.7K $ | 0.77 % |
| 55 | Beam Therapeutics Inc | 2,915 | 100K $ | 0.74 % |
| 56 | IMMUNITYBIO INC | 11,362 | 99.5K $ | 0.74 % |
| 57 | MIRUM PHARMACEUTICALS INC | 849 | 99.4K $ | 0.74 % |
| 58 | Praxis Precision Medicines Inc | 290 | 97.1K $ | 0.72 % |
| 59 | Rhythm Pharmaceuticals Inc | 867 | 96.3K $ | 0.71 % |
| 60 | ACADIA Pharmaceuticals Inc | 3,792 | 95.9K $ | 0.71 % |
| 61 | Intellia Therapeutics Inc | 5,161 | 87.3K $ | 0.65 % |
| 62 | Arcutis Biotherapeutics Inc | 3,227 | 84.6K $ | 0.63 % |
| 63 | Recursion Pharmaceuticals Inc | 20,066 | 73.6K $ | 0.55 % |
| 64 | SAREPTA THERAPEUTICS INC | 4,066 | 73.1K $ | 0.54 % |
| 65 | Summit Therapeutics Inc | 4,911 | 71.6K $ | 0.53 % |
| 66 | LEGEND BIOTECH CORP | 2,346 | 67.8K $ | 0.50 % |
| 67 | ADMA Biologics Inc | 8,088 | 67.7K $ | 0.50 % |
| 68 | Celcuity Inc | 582 | 60.9K $ | 0.45 % |
| 69 | GRAIL Inc | 751 | 51.3K $ | 0.38 % |
| 70 | Akero Therapeutics Inc | 1,848 | 0.2 $ |
Sector breakdown
- Health care 46.6 %
- Unattributed 53.4 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 89.2 %
- Ireland 2.7 %
- Bermuda 1.7 %
- Netherlands 1.5 %
- United Kingdom 1.2 %
- Germany 1.2 %
- Switzerland 1.2 %
- Denmark 0.9 %
- Cayman Islands 0.5 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 61 | 12M $ | 89.15 % |
| 2 | Ireland | 2 | 367.4K $ | 2.74 % |
| 3 | Bermuda | 1 | 223.2K $ | 1.67 % |
| 4 | Netherlands | 1 | 199.5K $ | 1.49 % |
| 5 | United Kingdom | 1 | 165K $ | 1.23 % |
| 6 | Germany | 1 | 156.1K $ | 1.16 % |
| 7 | Switzerland | 1 | 155.8K $ | 1.16 % |
| 8 | Denmark | 1 | 119.2K $ | 0.89 % |
| 9 | Cayman Islands | 1 | 67.8K $ | 0.51 % |
Cite this page
Titelia. "Holdings of Biotechnology Fund". https://titelia.com/en/funds/S000003711